The E6AP E3 ubiquitin ligase has been linked to the regulation of cell growth and to the cellular stress response. However, the specific stress conditions that are controlled by E6AP have not been defined. An important stress condition that controls cell growth is oxidative stress, where the levels of intracellular reactive oxygen species (ROS) regulate the appropriate cellular response. Here, we describe a novel role for E6AP in the control of oxidative stress response. Cells lacking E6AP expression have reduced capacity to accumulate ROS, and oxidative DNA damage, in response to 20% cell culture oxygen levels, treatment with hydrogen peroxide and expression of oncogenic RAS. This effect of E6AP is associated with the regulation of the anti-oxidant enzyme, Prx1, a previously identified target of E6AP, and can be corrected by downregulation of Prx1 or by reconstitution of E6AP expression. Consequently, cells with compromised E6AP have impaired senescent and apoptotic response to sub-lethal and lethal doses of oxidative stress, respectively. In a xenograft model, downregulation of E6AP renders transplanted tumours refractory to growth-suppressive effects of hydrogen peroxide. Our results provide the first demonstration that E6AP is an important regulator of ROS-mediated cellular senescence and cell death.
INTRODUCTION
Aerobic metabolism is intimately linked to the generation of reactive oxygen species (ROS), which are important regulators of key physiological processes, such as the control of cell growth. Therefore, organisms have evolved a tight regulatory mechanism that controls ROS levels. These include multiple anti-oxidant enzymes, such as catalase, superoxide dysmutase and peroxiredoxins, 1,2 which maintain redox homoeostasis in the cell. 3 Deregulation of these anti-oxidant enzymes alters ROS levels. Excessive generation of ROS triggers oxidative stress, associated with oxidative DNA damage and consequently the induction of cell cycle arrest, cellular senescence or cell death, depending on the severity of the cellular damage and type of cell. 4 For example, the ablation of peroxiredoxin 1 (Prx1) in mouse embryo fibroblasts results in elevated ROS levels, oxidative DNA damage and proliferative arrest; 5, 6 whereas, overexpression of Prx1 confers resistance to oxidative stress. 7 Cellular senescence and cell death have vital roles in tumour suppression by irreversibly arresting or by eradicating damaged cells with cancerous potential, respectively. 8, 9 Intracellular ROS levels increase in response to a variety of intrinsic and extrinsic factors. 1, 10 A common source of oxidative stress is a rise in ambient oxygen concentrations. Primary cells, such as murine embryonic fibroblasts (MEFs) exposed to standard culturing conditions (20% oxygen), accumulate oxidative DNA damage and consequently undergo premature senescence. [10] [11] [12] Similarly, direct exposure of MEFs to sub-lethal doses of hydrogen peroxide (H 2 O 2 ) results in the induction of cellular senescence. [13] [14] [15] [16] Interestingly, the senescent response can be prevented by culturing the cells under physiological oxygen concentrations (3%), or by supplementing the medium with a hydrogen peroxidescavenging agents, such as N-acetylcysteine. [10] [11] [12] An important trigger of ROS levels are activated oncogenes, such as H-Ras V12 , AML1-ETO or oncogenic EGFR orthologue, which require ROS to trigger cellular senescence. [17] [18] [19] [20] Therefore, ROS emerges as a major player in the induction of cellular senescence, thereby contributing to the physiological barrier that suppresses tumourigenesis. Despite the significant body of experimental evidence for the role of ROS in cellular senescence and cell death, the underlying mechanism that regulates ROS levels in this context is largely unknown.
E6AP is an E3 ubiquitin ligase being the prototype of the HECT sub-type of E3 ligases. 21 E6AP was originally identified as the cellular protein that is recruited by the human papilloma virus to promote the degradation of p53. [22] [23] [24] E6AP is encoded by the Ube3A locus, which is mutated in a neuro-developmental disorder called Angelman Syndrome (AS). 25 Recent studies have linked E6AP to the regulation of the cell cycle and the cellular response to stress. We have recently reported that E6AP is required for cellular senescence in MEFs, 26 whereas Nasu et al. 27 have identified the anti-oxidant enzyme, Prx1, as a novel E6AP target. In the current study, we identified a novel role for E6AP in the regulation of the cellular response to oxidative stress. We found that cells deficient for E6AP are defected in their ability to accumulate ROS levels, and consequently to respond to oxidative stress-induced senescence and cell death. This impairment is linked to the accumulation of the anti-oxidant enzyme Prx1, but can be restored by correcting Prx1 expression to normal levels. Our results define E6AP as a novel regulator of the cellular response to oxidative stress.
RESULTS
MEFs deficient for E6AP show proliferative advantage in 20% but not 3% oxygen and escape oxidative-stress induced senescence We have recently found that unlike wild-type (WT) primary MEFs, those deficient for E6AP are refractory to undergo senescence under standard tissue culture growth conditions. 26 The induction of cellular senescence in primary cells has been shown to be triggered by the accumulation of ROS and oxidative damage under growth conditions at 20% oxygen, but not under 3% oxygen levels. [10] [11] [12] We therefore asked whether the evasion of E6AP KO MEFs from senescence is linked to the oxidative stress generated under 20% oxygen levels. To address this question, we compared the growth rate of WT and E6AP KO MEFs cultured either in 20 or 3% oxygen over number of passages. Consistent with our previous findings, 26 we observed that E6AP KO MEFs cultured in 20% oxygen level continued to proliferate over 12 passages, whereas the growth of the normal MEF control was retarded from passage 7 onwards (Figure 1a ). On the other hand, in agreement with previous studies, we noticed that WT MEFs cultured in a more physiological oxygen level (3%) continued to proliferate at a steady rate beyond passage 7. Importantly, under this normal oxygen level, there was no difference in the growth rate between WT and E6AP KO MEFs. This result suggests that the growth advantage of the E6AP KO MEFs is largely contributed by their ability to overcome the oxidative stress caused by growth in 20% oxygen. As the growth retardation at passage 7 onwards is associated with cellular senescence, we compared the extent of senescent cells between WT and E6AP KO MEFs, under 20 and 3% oxygen. Staining the cells for SA-b-gal marker at passage 9 revealed the reduced extent of cellular senescence in the E6AP KO MEFs relative to WT controls under 20% oxygen condition. Consistent with the growth rate results (Figure 1a) , the extent of SA-b-gal positive cells was low and similar between the two genotypes under 3% oxygen levels (Figures 1b and c) . Collectively, these findings suggest that a loss of E6AP renders MEFs more resistant to oxidative stress-induced cellular senescence.
Loss of E6AP results in reduced accumulation of ROS As the high burden of ROS is a major cause of oxidative-stressinduced senescence, we hypothesized that the impaired senescent response of the E6AP KO MEFs may be due to reduced accumulation of ROS. To test this hypothesis, we compared the levels of ROS in WT and E6AP KO MEFs grown under standard culture conditions using DCF probe. 19 MEFs lacking E6AP exhibited a significant reduction (B2-fold) in ROS levels as compared with WT MEFs (Figures 2a and b) . Strikingly, the levels of ROS in the E6AP KO MEFs were comparable to those measured in the WT control cultured in 3% oxygen. This result suggested that the E6AP KO MEFs fail to accumulate ROS in response to the oxidative stress induced by standard culture conditions. To substantiate this notion, we treated WT and E6AP KO MEFs with increasing concentrations of hydrogen peroxide (H 2 O 2 ) and measured ROS accumulation. E6AP KO MEFs accumulated less ROS than the control WT MEFs (Figure 2c ), consistent with the observed difference in the basal ROS levels.
An important trigger of ROS accumulation under pathological condition is the activation of oncogenes such as Ras or Myc. 17, 20, 28 We have previously shown that a loss of E6AP impaired the senescent response of MEFs infected with H-Ras V12 and led to a faster growth in transplanted mice. 26 We therefore asked whether ROS accumulation is also impaired in the E6AP KO MEFs in response to activated Ras. For this purpose, early passage WT and E6AP KO MEFs were infected with H-Ras V12 and the levels of ROS was compared. E6AP KO accumulated significantly lower levels of ROS in response to activated Ras as compared with their WT counterparts (Figure 2d ), consistent with their impaired senescent response. 26 These experiments demonstrated that E6AP KO MEFs have impaired accumulation of ROS in response to a variety of stress signals. Next we asked whether this effect of E6AP loss holds in other cell types. For this purpose, basal ROS levels were compared between freshly isolated splenocytes derived from WT and E6AP KO mice. ROS levels were found to be lower in the E6AP KO cells (Figure 2e ). Further, to test whether this difference holds in human cells, we downregulated E6AP expression in the human colon adenocarcinoma cell line (RKO) using an inducible short hairpin RNA (shRNA) vector (Figure 4c ). Downregulation of E6AP expression reduced the basal levels of ROS as compared with the non-induced cells (Figure 2f ). Overall, these results demonstrate a novel role for E6AP in the regulation of ROS levels, both basal levels and induced, in mouse and human cells.
Cells lacking E6AP have impaired DNA damage accumulation Elevation in cellular ROS levels generates multiple stress signals, including a DNA damage response.
1,10 Based on our findings above, we asked whether E6AP-deficient cells have less DNA damage burden due to the impaired accumulation of ROS. We therefore compared the extend of DNA damage between WT and E6AP KO MEFs following treatment with hydrogen peroxide. Cells were stained for oxidative DNA damage lesion, 8-oxo-Guanine, [29] [30] [31] as well as for DNA double-strand breaks using anti-g-H2AX. 32, 33 As shown in Figure impairment more directly to ROS-induced DNA damage, we used antibody specific for 8-oxo-Guanine, which measures oxidative DNA damage. 31 Here too, E6AP KO MEFs showed a significant reduction in 8-oxo-Guanine staining as compared with WT cells (Figure 3b ). This result supports the link between the impaired ROS accumulation and the reduced DNA damage response.
Disruption of E6AP promotes upregulation of Prx1 and impaired response to oxidative stress It has been recently shown that E6AP regulates the proteasomal regulation of the anti-oxidant enzyme Prx1. 27 It was therefore tempting to propose that elevation of Prx1 expression may be responsible for the reduced ROS accumulation in the E6AP-deficient cells. To test this possibility, we compared the basal expression levels of Prx1 in various tissues between wt control and E6AP KO mice. Western blot analysis revealed an increased expression level of Prx1 protein in the spleen, liver, kidney, as well as in MEFs derived from E6AP KO as compared with the WT counterparts ( Figure 4a ). Consequently, we were able to demonstrate that Prx1 is more stable in E6AP KO cells (Figure 4b ). Further, we compared Prx1 expression levels in MEFs expressing oncogenic Ras and found higher levels in the E6AP KO MEFs than in WT controls (Figure 4c) E6AP regulates oxidative stress response K Wolyniec et al levels were increased upon downregulation of E6AP in RKO cells (Figure 4d ). To further establish that elevated Prx1 expression in the E6AP KO is due to E6AP deficiency, we reconstituted E6AP expression in the KO cells and measured the effect on Prx1 expression. For this purpose E6AP KO MEFs were infected with retrovirus expressing WT E6AP. This reconstitution resulted in a significant reduction of Prx1 (Figure 5a ) confirming that the observed effect of E6AP deficiency on elevation of Prx1 was specific to E6AP loss rather than a secondary adaptation of cells due to some other genomic alteration. Consistent with previously published data describing the critical role of the E3 ligase activity of E6AP in the regulation of Prx1, 27 reconstitution with a catalytic mutant of E6AP (C820A) failed to rescue Prx1 levels (Figure 5a) . Importantly, the reconstitution of wt E6AP expression resulted in the elevation of ROS in E6AP KO MEFs to levels just below those measured in WT MEFs (Figure 5b ). In contrast, reconstitution with a catalytic mutant of E6AP was less efficient in rescuing the impaired levels of ROS in E6AP KO MEFs. These experiments support the role of E6AP in the regulation of ROS levels and Prx1 expression. It further supports previous findings that E6AP acts as the E3 ligase of Prx1.
The above result supports the involvement of Prx1 in the effect of E6AP loss on ROS levels. To provide a more direct evidence for this link, we downregulated Prx1 levels in E6AP KO MEFs using retrovirus-mediated shRNA directed to Prx1 (Figure 5c ). Downregulation of Prx1 expression in E6AP KO cells restored normal levels of ROS comparable to ROS levels in WT MEFs (Figure 5d ). In addition, ectopic expression of Prx1 in E6AP WT MEFs (Figure 5e ) results in the reduction of ROS levels (Figure 5f ). To further substantiate the link between E6AP and Prx1 in the context of oncogenic signalling, Prx1 levels were downregulated in E6AP KO MEFs that were transduced with H-Ras V12 . Prx1 levels were then reconstituted by expression of Prx1 (Figure 5g) . Interestingly, the impaired ROS levels due to Prx1 downregulation was partially restored by reconstitution of Prx1 expression. Therefore, these experiments provide evidence supporting the direct role of E6AP in the regulation of intracellular ROS levels by controlling Prx1 expression.
Next we tested whether Prx-1-dependent reduction in ROS levels in E6AP-deficient cells (Figures 2 and 3) is responsible for the impaired response of these cells to oxidative stress. Normal primary cells and certain cancer cells undergo cellular senescence when exposed to sublethal doses of H 2 O 2 . [13] [14] [15] [16] We used a well-established protocol for induction of H 2 O 2 -induced senescence.
14,15 Young WT and E6AP KO MEFs (passage 3) were treated with low concentration (300 mM) of H 2 O 2 for 2 h. At 7 days following treatment, WT cells acquired flat and enlarged morphology characteristic for senescent cells (Figure 6a and Supplementary Figure S1 ), consistent with previous findings. 26 We further confirmed the senescent phenotype by showing that B40% of WT MEFs were positive for SA-b-gal (Figure 6b ), associated with a reduction in the proportion of cycling cells as measured by flow cytometry (Figure 6c ). In contrast, MEFs lacking E6AP were more refractory to H 2 O 2 -induced senescence (Figures  6a-c) . The impaired response of E6AP KO cells to H 2 O 2 treatment was fully restored by the reconstitution of E6AP expression, but not with a catalytic mutant of E6AP (C820A) (Figure 6d,  Supplementary Figure S2) . Importantly, downregulation of Prx1 in the E6AP KO cells greatly restored the senescent response to H 2 O 2 treatment (Figure 6d, Supplementary Figure S2) , which further supports the role of Prx1 in the impaired response of E6AP-deficient cells. Similar results were obtained in RKO cells with inducible downregulation of E6AP (Figures 7a-c, Supplementary  Figures S3A-C) . These results show that E6AP is required for the senescent response to sublethal dose of H 2 O 2 , and that this effect is mediated, at least in part, by Prx1 regulation.
We extended our analysis to include lethal doses of H 2 O 2 . The experiments described above with WT versus E6AP KO MEFs, and with inducible KD of E6AP in RKO cells were repeated with 0.5 mM and 1 mM H 2 O 2 for 2 h, and the effect on cell death was measured 24 h later. Consistent with the sub-lethal dose, E6AP KO MEFs and RKO cells with downregulated E6AP expression showed B30% reduction in the extent of cell death induced by H 2 O 2 , as compared with their normal counterparts (Figures 6e and 7d and Supplementary Figure S3D) . Similarly, downregulation of Prx1 enhanced the sensitivity of the E6AP KO MEFs to H 2 O 2 -mediated cell death (Figure 6e) . Collectively, these results provide strong evidence supporting the role of E6AP in the regulation of oxidative stress response through Prx1. 
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To demonstrate whether regulation of oxidative stress by E6AP has relevance in vivo, we compared the effect of E6AP expression on the response of tumour cells to H 2 O 2 using a xenograft mouse model. For this purpose, the colon cell line RKO has been infected with lentivirus expressing shRNA to E6AP under the tetracyclineresponsive promoter. E6AP expression was inducibly knockdown by treatment of cells with doxycycline. We also confirmed that H 2 O 2 modulates Prx1 expression in these cells (Figure 7e ). Treatment of mice with H 2 O 2 has been previously demonstrated to exhibit anti-tumour effects in vivo. [34] [35] [36] As shown in Figure 7f , treatment of mice with doxycycline had little effect on the growth rate of transplanted tumours. Because of variation between mice, this difference was not statistically significant. In contrast, treatment of mice with H 2 O 2 slowed the growth rate of the RKO control tumours (Figure 7g ). Consistent with our findings in cultured cells, downregulation of E6AP in RKO cells using doxycylin-rendered tumours more refractory to the anti-tumour effects of H 2 O 2 (Figures 7g and h) . These results support our overall conclusion that E6AP regulates oxidative stress response both in vitro and in vivo.
DISCUSSION
Intracellular ROS are being increasingly recognized as crucial mediators of multiple cellular functions including cell cycle control, inflammatory response and tumour suppression. 1 The levels of ROS are influenced by intrinsic factors such as activated oncogenes and extrinsic factors such as ambient oxygen levels. ROS levels are regulated by a network of antioxidant enzymes. 10 Pertubation in the levels of the antioxidant enzymes can therefore have deleterious effects on ROS levels and consequently lead to oxidative stress. However, the regulation of the antioxidant enzymes is only partially understood. In this study, we identified a novel function for E6AP in the regulation of intracellular ROS levels. Cells deficient for E6AP fail to accumulate ROS levels in response to high ambient oxygen level (20%), direct exposure to H 2 O 2 or exposure to activated Ras (Figure 2) . Consequently, the response of E6AP-deficient cells to these oxidative stress conditions was impaired, as measured by lower extent of senescence and apoptosis (Figures 1, 6 and 7) .
In search for the mechanism underlying the impaired response to E6AP to oxidative stress, we tested whether the anti-oxidant Prx1, a recently identified target of E6AP, is involved. E6AP promotes the ubiquitination and proteasomal degradation of Prx1, 27 however the context of this regulation or its functional consequence was unknown. We show that Prx1 protein levels are elevated in E6AP-deficienct cells and tissues (Figure 4) . Importantly, downregulation of Prx1 largely rescues the impaired response of E6AP KO cells to oxidative stress. Therefore, the E6AP-Prx1 axis has an important regulatory role in cellular oxidative stress responses.
The essential role of ROS in tumour suppression in vitro and in vivo has been demonstrated in multiple contexts in mice and humans, whereby ROS is an important trigger of cell death or cellular senescence. 37 Major oncogenes implicated in human cancers, including Ras and AML1-ETO, trigger ROS accumulation, which is required for oncogene-induced senescence. 10, [17] [18] [19] We have recently discovered a novel role for E6AP in the regulation of cellular senescence in response to oncogenic Ras. E6AP KO MEFs expressing activated Ras escape cellular senescence and are highly tumourigenic in vivo as compared with their wt counterparts. Our current study provides a molecular explanation for this response. Further, our demonstrated link between E6AP and Prx1 in the cellular response to oxidative stress is consistent with previous findings reporting that disruption of Prx1 in primary fibroblasts elevated ROS levels with a subsequent proliferative arrest. 5, 6 Although, the authors did not measure directly the induction of cellular senescence in their study, it is E6AP regulates oxidative stress response K Wolyniec et al reasonable to speculate that these cells underwent ROS-induced cellular senescence. Likewise, ectopic expression of Prx1 in endothelial cells accelerated their growth rates. 7 These studies support our findings of a role for the E6AP-Prx1 axis in the regulation of ROS-induced cellular senescence.
Although little is known about the involvement of E6AP and Prx1 in human cancers, our findings are consistent with a recent study reporting downregulation of E6AP in invasive breast cancer samples. 38 Intriguingly, Prx1 is frequently overexpressed in breast cancer patients. 39 It is therefore tempting to speculate that the downregulation of E6AP is linked to the elevated levels of Prx1 in breast cancer cells, and that this provides a molecular explanation for the escape of breast cancer cells from ROS-induced cellular senescence. Future studies are required to test this hypothesis.
MATERIALS AND METHODS
Cell culture E6AP KO mice were backcrossed onto C57/B6 background for 10 generations and MEFs were generated as previously described. 26 
Immunoblotting and antibodies
Western blot analysis was carried as previously described. 26 The antibodies used were anti-rabbit Prx1 (07-609, Upstate/Millipore, Billerica, MA, USA), anti-actin (Ac-40; Sigma) and anti-E6AP (E6AP-330, Sigma). Secondary goat anti-rabbit IgG (926-32211) or goat anti-mouse IgG (926-32220) antibodies conjugated with infrared dyes (IRDye) were purchased from LI-COR (Lincoln, NE, USA).
Immunofluorescence
Cells were fixed with 4% paraformaldehyde for 15 min, permeabilized (0.1% Triton X) for 5 min, blocked (1% bovine serum albumin-phosphatebuffered saline) for 20 min, then stained with anti-H2 AXe (ab22551, Abcam, Cambridge, MA, USA) and anti-8-oxoG (Santa Cruz, Santa Cruz, CA, USA, sc-130914) and detected by Alexa Fluor 488-conjugated secondary antibodies (Molecular Probes, Invitrogen, Life Technologies Australia Pty Ltd, Mulgrave, VIC, Australia). DNA was stained with DAPI. Cells were visualized in Olympus confocal microscope (Olympus Australia Pty Ltd, Mt Waverley, VIC, Australia).
Retroviral and lentiviral vectors and gene transfer
Retroviral infection was performed as previously described. 40 Reconstitution of E6AP expression was done as previously described. 26 For downregulation of Prx1, the shRNA sequence (5 0 -GCTCAGGATTATGGAGTCTTA-3 0 ) 41 was subcloned into pSUPERretro. 42, 43 E6AP was downregulated by using lentiviral vector expressing the following shRNA sequence: 5 0 -GAAGCAGTTGTATGTGGAA-3 0 . pCAG-Prx1 expression plasmid was kindly provided by Ikuo Shoji. 27 Fugene reagent (Promega, Alexandria, NSW, Australia) was used for transfections. , set as 100%) were randomized to control group, receiving saline (f), and H 2 O 2 group (g), treated with 1 mM H 2 O 2 injected intratumourally every 2 days. Doxycycline (dox) was supplemented in the drinking water to downregulate E6AP. Tumours were measured every 4 days and relative tumour volumes were plotted on the graphs; n ¼ 10/group; *Po0.05. (h) Tumours were excised and weighed at day 20; *Po0.05. Values are means±s.d. A full colour version of this figure is available at the Oncogene journal online.
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